![Patient Centricity in IBD Treatment: An Interview with Dr Corey Siegel at the 13th Congress of ECCO - European Medical Journal Patient Centricity in IBD Treatment: An Interview with Dr Corey Siegel at the 13th Congress of ECCO - European Medical Journal](https://emj.emg-health.com/wp-content/uploads/sites/2/2018/04/Patient-Centricity-in-IBD-Treatment-An-Interview-with-Dr-Corey-Siegel-at-the-13th-Congress-of-ECCO-940x564.jpg)
Patient Centricity in IBD Treatment: An Interview with Dr Corey Siegel at the 13th Congress of ECCO - European Medical Journal
1 ECCO-ESGAR Guideline for Diagnostics in Inflammatory Bowel Disease Agreed Author-List order: Note: Affiliations will be insert
![PDF) N-ECCO Consensus statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis PDF) N-ECCO Consensus statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis](https://i1.rgstatic.net/publication/247156190_N-ECCO_Consensus_statements_on_the_European_nursing_roles_in_caring_for_patients_with_Crohn's_disease_or_ulcerative_colitis/links/5d1b6af0a6fdcc2462b92ebb/largepreview.png)
PDF) N-ECCO Consensus statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis
![PDF) Placebo Effect on the Health-related Quality of Life of Inflammatory Bowel Disease Patients: A Systematic Review With Meta-analysis PDF) Placebo Effect on the Health-related Quality of Life of Inflammatory Bowel Disease Patients: A Systematic Review With Meta-analysis](https://i1.rgstatic.net/publication/326399984_Placebo_Effect_on_the_Health-related_Quality_of_Life_of_Inflammatory_Bowel_Disease_Patients_A_Systematic_Review_With_Meta-analysis/links/5df1f863a6fdcc28371a426d/largepreview.png)
PDF) Placebo Effect on the Health-related Quality of Life of Inflammatory Bowel Disease Patients: A Systematic Review With Meta-analysis
![Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis - Digestive and Liver Disease Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis - Digestive and Liver Disease](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/2d8ce941-c21d-47d2-bfdc-8ad0f0503aac/gr1.jpg)
Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis - Digestive and Liver Disease
横浜市立大学 消化器内科学教室 - 2016/2/14-17 ECCO 2018 in Vienna ウィーンで開催されたEuropean Crohn's and Colitis Organisation Congress 2018にて,当教室から附属市民総合医療センター IBDセンター の西尾 匡史 大学院生が発表を行いました ...
![PDF) Internet-orientated Assessment of QOL and Actual Treatment Status in Japanese Patients with Inflammatory Bowel Disease: The 3I survey PDF) Internet-orientated Assessment of QOL and Actual Treatment Status in Japanese Patients with Inflammatory Bowel Disease: The 3I survey](https://i1.rgstatic.net/publication/274258279_Internet-orientated_Assessment_of_QOL_and_Actual_Treatment_Status_in_Japanese_Patients_with_Inflammatory_Bowel_Disease_The_3I_survey/links/5c0912e192851c39ebd77106/largepreview.png)